ClinicalTrials.gg
RecruitingNCT032409655SUpdated Dec 1, 2023

Changes in Sensitivity, Taste and Smell in Stroke Patients

An observational study in Dysphagia and Stroke, sponsored by University of Giessen. Recruiting at 1 site in Germany. Open to participants aged 18 Years and older, including healthy volunteers. Per ClinicalTrials.gov, last updated 2023-12-01.

Sponsored by University of Giessen · Observational

How we know

From the registry’s dates

  • Primary completion was expected by Feb 2025, 1 year 9 months ago, but the record still lists the study as recruiting.
  • Started Oct 2017; still recruiting 9 years 1 month later.

Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →

Study type
Observational
Model
Case-only
Time perspective
Prospective
Enrollment
200
Ages
18 Years and older
Sex
All
01

Where this study stands

Counted across the records on this site · 2026-11-22

Among 27 studies in Deglutition Disorders with a site in Germany — 6 open to participants now, 6 under way, none of them phase 3. Deglutition Disorders · Germany.

Started
2017
with 3 others
Observational
9 of 27
4 open now
Registered
13th of 27
by date
Lead sponsor
4 of 27
University of Giessen

Among the 27 studies in Deglutition Disorders with a site in Germany, this one is one of 4 that started in 2017, is one of 9 observational ones, and was the 13th registered.

Deglutition Disorders

875 studies on the registry are indexed under Deglutition Disorders; 237 are open to participants now.

Browse Deglutition Disorders studies →

Open to participants now

6 of the 27 studies in Deglutition Disorders with a site in Germany are open now. Recruiting first, the newest first:

All 6 open studies →

A study can be open while its sites in Germany have not opened yet or have stopped. Only those recruiting at a site in Germany →

Who these studies take

Of the 137 Deglutition Disorders studies recruiting now, 75 (55%) set no upper age limit and 26 (19%) stop at 75 or younger; 15 take children under 18; 20 take healthy volunteers.

This study: 18 Years and older · all sexes · healthy volunteers too.

The full table on the hub →

This tab as a report to print or save as PDF → With an account.

Was this useful?
Get alerts for this landscapeDownload CSVNarrow it in search →With an account: a weekly mail of what changed among 27 studies in Deglutition Disorders with a site in Germany, or all of them as a file.
02

Study summary

This study evaluates changes in swallowing using endoscopic swallowing studies and measuring of pharyngeal sensitivity, taste and smell in stroke patients. Younger (\<60 years) and older (>60 years) volunteers will serve as control.

Read the detailed description

Stroke is the second leading cause of death. At least 50% of stroke patients develop dysphagia, leading to aspiration pneumonia, which is the main cause of death in stroke [2].

It is assumed that normal sensitivity is vital for aspiration-free swallowing and for the triggering of the swallowing reflex.

Ali et al. demonstrated aspiration-free swallowing in healthy volunteers who underwent local anaesthesia of oral and pharyngeal structures [1]. Power et al. showed a reduced sensitivity of pharyngeal structures in stroke patients prone to aspiration [3].

By combining measuring sensitivity and flexible endoscopic swallowing studies, this study further investigates the role of sensitivity in swallowing Neuropsychological deficits of swallowing, such as swallowing apraxia or buccal hemineglect, is assessed by neuropsychological testing.

Additionally, there is no systematic research investigating the change in smell and taste in correlation with changes in stroke patients

03

Conditions studied

  • Dysphagia
  • Stroke
04

Who can participate

Ages eligible
18 Years and older
Sexes eligible
All
Accepts healthy volunteers
Yes
Sampling method
Non-probability sample

Study population

Stroke patients are recruited in a university hospital's department of neurology.

Volunteers >60years are recruited in a trauma surgery ward at the same university hospital.

Volunteers \<60 are recruited without specified characteristics (aside from in-/exclusion criteria).

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

Volunteers:

Stroke patients:

  • informed consent
  • new supratentorial stroke (\<72 hours old) confirmed by CT (computed tomography) or MRI (magnetic resonance imaging)

Exclusion criteria

Exclusion Criteria:

  • pre-existing stroke oder dysphagia
  • extensive white matter lesions in CT- or MRI-scan
  • allergies to odorous substances or flavoring
  • for FEES (flexible endoscopic evaluation of swallowing), CT or MRI (stroke patients only)
Terms in these criteria, in plain language(2)

Underlined terms in the criteria open these too. Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.

Informed consent

Before you join, the study team explains what taking part involves — its purpose, what happens, the risks and possible benefits — and answers your questions, so you can decide freely. Consent is usually recorded on a form (the informed consent form, ICF) signed by you or, where the law allows, by someone legally authorized to decide for you.

You can keep asking questions during the study, you are told of new information that matters, and you can choose to leave at any time.

Contraindication

A reason a treatment, test or procedure should not be given to a particular person, such as an allergy, another illness or a medicine they take.

05

Study design

Observational model
Case-only
Time perspective
Prospective
Enrollment
200 participants (estimated)
Patient registry
No

Groups and cohorts

  • Volunteers <60 years

    Volunteers, who are able to consent to participation in the study, as control.

    Other: Sensitivity threshold · Diagnostic Test: Taste-/smell-test

  • Volunteers >60 years

    Volunteers, who are able to consent to participation in the study, as control.

    Other: Sensitivity threshold · Diagnostic Test: Taste-/smell-test

  • Stroke patients

    Stroke patients with supratentorial stroke, who are able to consent to participation in the study.

    Diagnostic Test: FEES (flexible endoscopic evaluation of swallowing) · Other: Sensitivity threshold · Diagnostic Test: Taste-/smell-test · Diagnostic Test: Neuropsychological testing

Interventions

  • Diagnostic testFEES (flexible endoscopic evaluation of swallowing)

    Endoscopical swallowing study in stroke patients only

  • OtherSensitivity threshold

    Determining sensitivity threshold using a pudendal electrode

  • Diagnostic testTaste-/smell-test

    Taste-/smell-test

  • Diagnostic testNeuropsychological testing

    Neuropsychological testing for neglect, agnosia

06

What researchers measure

Primary outcomes

  1. Dysphagia

    Changes found in endoscopic swallowing study : Presence and severity of dysphagia (measured with Rosenbek's Penetration/Aspiration-scale)

    Time frame: 96 hours after initial symptoms

Secondary outcomes

  1. Neuropsychological deficits

    Agnosia, neglect

    Time frame: 96 hours after initial symptoms

  2. Lesion site

    Side, vascular territory, swallowing relevant structures

    Time frame: 96 hours after initial symptoms

  3. Sensitivity

    Sensitivity of faucial pillar region

    Time frame: 96 hours after initial symptoms

  4. Taste/Smell

    Smell-/Taste-score

    Time frame: 96 hours after initial symptoms

07

Study locations

1 of 1 sites recruiting
08

References and documents

Publications

  • Ali GN, Laundl TM, Wallace KL, Shaw DW, Decarle DJ, Cook IJ. Influence of mucosal receptors on deglutitive regulation of pharyngeal and upper esophageal sphincter function. Am J Physiol. 1994 Oct;267(4 Pt 1):G644-9. doi: 10.1152/ajpgi.1994.267.4.G644. PubMed 7943330 ↗
  • Kidd D, Lawson J, Nesbitt R, MacMahon J. Aspiration in acute stroke: a clinical study with videofluoroscopy. Q J Med. 1993 Dec;86(12):825-9. PubMed 8108539 ↗
  • Power ML, Hamdy S, Singh S, Tyrrell PJ, Turnbull I, Thompson DG. Deglutitive laryngeal closure in stroke patients. J Neurol Neurosurg Psychiatry. 2007 Feb;78(2):141-6. doi: 10.1136/jnnp.2006.101857. Epub 2006 Sep 29. PubMed 17012336 ↗
  • Braun T, Doerr JM, Peters L, Viard M, Reuter I, Prosiegel M, Weber S, Yeniguen M, Tschernatsch M, Gerriets T, Juenemann M, Huttner HB, Hamzic S. Age-related changes in oral sensitivity, taste and smell. Sci Rep. 2022 Jan 27;12(1):1533. doi: 10.1038/s41598-022-05201-2. PubMed 35087097 ↗
  • Braun T, Hamzic S, Doerr JM, Peters L, Viard M, Reuter I, Prosiegel M, Weber S, Yenigun M, Tschernatsch M, Gerriets T, Juenemann M. Facilitation of oral sensitivity by electrical stimulation of the faucial pillars. Sci Rep. 2021 May 24;11(1):10762. doi: 10.1038/s41598-021-90262-y. PubMed 34031508 ↗

Individual participant data

Plan to share: Undecided

09

Timeline

Tracking since Sep 25, 2026
ElapsedEstimatedEstimated, not yet reachedSimilar studies: half by the dot; the band is the middle halfHalf of similar studies reached it by the dot; the band is the middle half, from a quarter to three quarters

Started Oct 2017 (actual). Primary completion is estimated for Feb 2025, 88 months after the start.

Of 116 non-industry observational studies under Deglutition Disorders, half reached primary completion within 25 months of starting (the median), counting those still running; a quarter within 11 and three quarters within 52. This study's planned 88 months is above that.

Counting every sponsor, half of 119 studies reached it within 25 months; a quarter within 11 and three quarters within 52.

How these figures are worked out, and which studies are left out of them.

Registered
Jul 28, 2017
First posted
Aug 7, 2017
StartActual
Oct 1, 2017
Primary completionEst.
Feb 2025
CompletionEst.
Dec 2026
Last update
Dec 1, 2023
What these dates mean
Start.
When the first participant enrolled; while estimated, when the study expects to open to recruitment.
Primary completion.
When the last participant was examined or treated to collect data for the study's main question, its primary outcome. A study that stopped early gives the date its data collection stopped.
Completion.
When the last participant's last visit took place, for every outcome, secondary ones and side effects included: the end of the study. Often later than primary completion, sometimes the same day.
Actual and Est.
Actual means the registry says the date has happened. Est. (estimated) is a date the sponsor plans or expects. It can still move, and the sponsor is expected to change it to actual once it has passed.
No changes since tracking began. The registry record was last updated on Dec 1, 2023, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT03240965
Lead sponsor
University of Giessen
Responsible party
Tobias Braun (Principal Investigator, University of Giessen) — Principal investigator
First posted
Aug 7, 2017
Start date
Oct 1, 2017
Primary completion
Feb 2025 (estimated)
Completion
Dec 2026 (estimated)
Last update
Dec 1, 2023

Study contacts

Tobias Braun, M.D.
Contact
tobias.braun@neuro.med.uni-giessen.de
+49(0)-641-985 ext. 56827
Tobias Braun, M.D.
principal investigator · University Giessen

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Interested in this study?

Eligibility is decided by the study team. Share this record with your doctor or contact the team directly.

Contact study team

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion